324 related articles for article (PubMed ID: 11794865)
1. Hepatitis C treatment, HAART and side effects.
TreatmentUpdate; 2001; 13(7):7-8. PubMed ID: 11794865
[No Abstract] [Full Text] [Related]
2. [HIV and hepatitis C coinfection].
Stoehr A; Brinkmann K; Sabranski M
MMW Fortschr Med; 2008 Apr; 150 Spec No 1():54-5, 57. PubMed ID: 19024919
[No Abstract] [Full Text] [Related]
3. Catatonia associated with pegylated interferon-α 2b and ribavirin for hepatitis C.
Quinn D; Kuchler E; Deming P; Arora S
Psychosomatics; 2012; 53(4):400-1. PubMed ID: 22748752
[No Abstract] [Full Text] [Related]
4. [Genotype 1 superresponder treat for only 24 weeks].
MMW Fortschr Med; 2005 Dec; 147(51-52):69. PubMed ID: 16402717
[No Abstract] [Full Text] [Related]
5. HCV infection in the setting of HIV: prevalence, disease, treatment.
Laurence J
AIDS Read; 2006 Mar; 16(3):115-6. PubMed ID: 16538952
[No Abstract] [Full Text] [Related]
6. Interferon for hepatitis C patients with psychiatric disorders.
Rifai MA; Bozorg B; Rosenstein DL
Am J Psychiatry; 2004 Dec; 161(12):2331-2; author reply 2332-4. PubMed ID: 15569919
[No Abstract] [Full Text] [Related]
7. "Hepatitis C (HCV) treatment is not a "one size fits all".
Bukeirat FA; Bukeirat MM
W V Med J; 2012; 108(2):20, 22-4. PubMed ID: 22655431
[TBL] [Abstract][Full Text] [Related]
8. Anterior ischemic optic neuropathy in a patient with hepatitis C treated with interferon-alpha and ribavirin.
Knyazer B; Lifshitz T; Marcus M; Kratz A; Zlotnik A; Levy J
Isr Med Assoc J; 2011 Apr; 13(4):251-3. PubMed ID: 21598818
[No Abstract] [Full Text] [Related]
9. Interferon for hepatitis C patients with psychiatric disorders.
Asnis GM; De La Garza R; Rego SA; Henderson MA; Reinus JF
Am J Psychiatry; 2004 Dec; 161(12):2332; author reply 2332-4. PubMed ID: 15569920
[No Abstract] [Full Text] [Related]
10. Peginterferon- and ribavirin-induced bipolar episode successfully treated with lamotrigine without discontinuation of antiviral therapy.
Navinés R; Castellví P; Solà R; Martín-Santos R
Gen Hosp Psychiatry; 2008; 30(4):387-9. PubMed ID: 18585548
[No Abstract] [Full Text] [Related]
11. Occurrence of hepatocellular carcinoma 13 years after successful antiviral treatment for HCV infection.
Puoti C; Lanzetta G; Scotti E
J Gastrointestin Liver Dis; 2016 Sep; 25(3):408-9. PubMed ID: 27689211
[No Abstract] [Full Text] [Related]
12. Alopecia universalis: a rare side effect seen on chronic hepatitis C treatment with peg-IFN and ribavirin.
Demirturk N; Aykin N; Demirdal T; Cevik F
Eur J Dermatol; 2006; 16(5):579-80. PubMed ID: 17101483
[No Abstract] [Full Text] [Related]
13. [Information for patients. Treatment of acute hepatitis C].
Otón Nieto E
Rev Esp Enferm Dig; 2011 Oct; 103(10):549. PubMed ID: 22054273
[No Abstract] [Full Text] [Related]
14. [Eliminating the gray zone. What can be done in normal ALT values?].
MMW Fortschr Med; 2004 Apr; 146 Spec No 1():75. PubMed ID: 15373059
[No Abstract] [Full Text] [Related]
15. Lingual hyperpigmentation from pegylated interferon and ribavirin treatment of hepatitis C.
Farshidi D; Chiu MW
J Am Acad Dermatol; 2010 Jan; 62(1):164-165. PubMed ID: 20082904
[No Abstract] [Full Text] [Related]
16. Peginterferon and ribavirin for chronic hepatitis C.
Hoofnagle JH; Seeff LB
N Engl J Med; 2006 Dec; 355(23):2444-51. PubMed ID: 17151366
[No Abstract] [Full Text] [Related]
17. Erythema Annulare Centrifugum in the Era of Triple Therapy With Boceprevir Plus Pegylated Interferon α-2b and Ribavirin for Hepatitis C Virus Infection.
di Meo N; Stinco G; Fadel M; Errichetti E; Trevisan G
J Cutan Med Surg; 2015; 19(3):203-4. PubMed ID: 26060126
[No Abstract] [Full Text] [Related]
18. Severe renal impairment during triple therapy with telaprevir.
Carrier P; Chambaraud T; Vong C; Guillaudeau A; Debette-Gratien M; Jacques J; Legros R; Sautereau D; Essig M; Loustaud-Ratti V
Clin Res Hepatol Gastroenterol; 2014 Sep; 38(4):e69-71. PubMed ID: 24461554
[No Abstract] [Full Text] [Related]
19. [Healing hepatitis C infections. Pegylated interferon alfa-2a opens new perspectives].
MMW Fortschr Med; 2003 Jun; 145(26):52-3. PubMed ID: 12916339
[No Abstract] [Full Text] [Related]
20. A change of peginterferon may permit continuation of antiviral therapy in hepatitis C virus-infected patients with interstitial pneumonitis.
Shimada M; Yoshida S; Kornek M; Kim SJ; Schuppan D
Liver Int; 2010 Nov; 30(10):1552-4. PubMed ID: 20557455
[No Abstract] [Full Text] [Related]
[Next] [New Search]
